AstraZeneca Sues Actavis Over Planned Generic Vimovo
AstraZeneca AB sued Actavis Inc. in New Jersey federal court Friday to block the generic-drug maker from selling a version of the arthritis drug Vimovo....To view the full article, register now.
Already a subscriber? Click here to view full article